(Q37822917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

Eduardo Büchele Rodrigues

18 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Stephan Michels

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Annette Hager

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stefan Mennel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jörg C Schmidt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hans-Martin Helb

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michel E Farah

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

22 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

70-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21176118%20AND%20SRC:MED&resulttype=core&format=json

Intravitreous injection: retrospective study on 2028 injections and their side effects

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Macular hole formation in the presence of a pigment epithelial detachment after three consecutive intravitreal antivascular endothelial growth factor injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Risks of intravitreous injection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Short-term complications of intravitreal injections of triamcinolone and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Intravitreal injection. Monitoring to avoid postoperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Incidence of damage to the crystalline lens during intravitreal injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Unsealed sclerotomy after intravitreal injection with a 30-gauge needle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Complications in patients after intravitreal injection of bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Age-dependent changes in the basal retinovitreous adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X

Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02064.X